Dr. Àlex García-Faura Joins SEGO Executive Board

Strengthening scientific leadership in reproductive medicine

FutureLife is proud to congratulate Dr. Àlex García-Faura, Scientific Director of Institut Marquès and Vice-Chair of Research of the FutureLife Medical Advisory Board, on his appointment as a Board Member (Vocal) of the Executive Board of the Sterility and Infertility Section of the Spanish Society of Gynecology and Obstetrics (SEGO) for the 2026–2030 term.

This appointment recognises Dr. García-Faura's long-standing contribution to reproductive medicine, scientific research, and clinical innovation. In his new role, he will actively contribute to shaping the strategic direction of one of Spain's leading professional societies, supporting research initiatives, education, and the continued advancement of fertility care.

At FutureLife, we believe that scientific excellence is the foundation of outstanding patient care. Through our Medical Advisory Board and the expertise of our specialists across Europe, we are committed to advancing evidence-based medicine, supporting clinical research, and driving innovation that improves outcomes for patients.

Dr. García-Faura's appointment further strengthens this commitment and highlights the important role our experts play in influencing the future of reproductive healthcare both nationally and internationally.

Congratulations to the newly elected Executive Board

We would also like to congratulate the entire newly elected leadership team of SEGO's Sterility and Infertility Section:

President: Dr. José Serna López

Vice President: Dr. Andrea Bernabeu García

Secretary: Dr. Alexandra Izquierdo Rodríguez

Board Members (Vocales): Dr. Àlex García-Faura Cirera, Dr. Silvia Iniesta Pérez and Dr. Julio Herrero García

We wish Dr. García-Faura and all members of the newly elected Executive Board every success over the coming four years. We look forward to seeing their collective leadership continue to advance research, education and innovation in reproductive medicine, benefiting both the scientific community and patients across Spain and beyond.

At FutureLife, we remain dedicated to supporting scientific leadership that helps shape the future of fertility care worldwide.